GlassScriptPhysician profile
Paul R Gregory
NPI 1427166453
$7,933.82
in general payments reported to CMS, 2019-2025
7 companies · $449 in 2025
The $449 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $3,978 · 2021: $65.68 · 2022: $75.45 · 2024: $2,778 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Travel and Lodging: $1,119 · Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Travel and Lodging | $1,119.27 |
| Food and Beverage | $607.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $6,737.41 | 2020-2024 | |
| Zimmer Biomet Holdings, INC. | $751.94 | 2019-2025 | Arcos |
| Depuy Synthes Sales INC. | $291.04 | 2019-2025 | Na |
| Dynasplint Systems INC. | $65.68 | 2021 | |
| Boston Scientific Corporation | $49.70 | 2022 | |
| Ethicon US, LLC | $25.75 | 2022 | |
| Acell, INC. | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.